home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

MEI Pharma, Inc. - Common Stock (NQ:MEIP)

3.070 UNCHANGED

Last Price Updated: 4:00 PM EDT, Sep 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MEI Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

MEI Pharma Appoints Human Resources Executive Anne Frese as Chief People Officer

June 22, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma and Kyowa Kirin Report Clinical Data on Zandelisib at European Hematology Association 2022 Hybrid Congress

June 10, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022

June 04, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 01, 2022

From MEI Pharma, Inc.

Via Business Wire

18 Stocks Moving in Wednesday's Pre-Market Session ↗

June 01, 2022

Gainers Endo International plc (NASDAQ: ENDP) rose 46.1% to $0.7710 in pre-market trading after gaining over 12% on Tuesday.

Via Benzinga

MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation at the American Society of Clinical Oncology Annual Meeting 2022

May 26, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights

May 23, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI ALERT: Bragar Eagel & Squire, P.C. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm

May 18, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm

May 17, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors

May 17, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

May 17, 2022

On Tuesday, 123 stocks made new 52-week lows.

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors

May 17, 2022

From Law Offices of Howard G. Smith

Via Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm

May 17, 2022

From The Schall Law Firm

Via Business Wire

MEI Pharma to Present at the H.C. Wainwright Global Investment Conference 2022

May 17, 2022

From MEI Pharma, Inc.

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of MEI Pharma, Inc. (MEIP) on Behalf of Investors

May 16, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in MEI Pharma, Inc. with Losses of $100,000 to Contact the Firm

May 16, 2022

From The Schall Law Firm

Via Business Wire

Rosen Law Firm Encourages MEI Pharma, Inc. Investors with Losses to Inquire About Class Action Investigation – MEIP

May 16, 2022

From Rosen Law Firm

Via Business Wire

MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress

May 12, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 02, 2022

From MEI Pharma, Inc.

Via Business Wire

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗

April 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Via Benzinga

MEI Pharma Announces Two Presentations at the American Association for Cancer Research Annual Meeting 2022

April 08, 2022

From MEI Pharma, Inc.

Via Business Wire

MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

April 01, 2022

From MEI Pharma, Inc.

Via Business Wire

Analyzing Mei Pharma Inc's Short Interest ↗

March 28, 2022

Mei Pharma Inc's (NASDAQ:MEIP) short percent of float has risen 10.86% since its last report. The company recently reported that it has 7.31 million shares sold short, which is 6....

Via Benzinga

Expert Ratings For MEI Pharma ↗

March 25, 2022

Analysts have provided the following ratings for MEI Pharma (NASDAQ:MEIP) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...

Via Benzinga

Mid-Afternoon Market Update: Dow Falls 30 Points; Cutera Shares Spike Higher ↗

March 25, 2022

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday. The Dow traded down 0.09% to 34,677.25 while the NASDAQ fell...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

64 Biggest Movers From Friday ↗

March 28, 2022

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...

Via Benzinga

Analysts Cut Price Target On MEI Pharma As Stock Falls To 52-Week Low After Zandelisib Update ↗

March 25, 2022

The FDA crushed MEI Pharma Inc's (NASDAQ: MEIP) hopes of winning accelerated approval for its PI3K inhibitor, zandelisib, on the strength of phase 2 data. In the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 25, 2022

Via Benzinga

Mid-Day Market Update: Nasdaq Down 1%; Icosavax Shares Plummet ↗

March 25, 2022

U.S. stocks pared gains midway through trading, with the Nasdaq Composite dropping 1% on Friday. The Dow traded up 0.02% to 34,715.99 while the NASDAQ fell 1.02% to 14,045.00...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com